Carnahan, Ryan M.

A Systematic Review of Amnestic and Non-Amnestic Mild Cognitive Impairment Induced by Anticholinergic, Antihistamine, GABAergic and Opioid Drugs

Tannenbaum, C., Paquette, A., Hilmer, S., Holroyd-Leduc, J., & Carnahan, R. (2012) · Drugs & Aging

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 241

Anticholinergic Medication Use and Risk of Dementia Among Elderly Nursing Home Residents with Depression

Chatterjee, S., Bali, V., Carnahan, R. M., Johnson, M. L., Chen, H., & Aparasu, R. R. (2016) · The American Journal of Geriatric Psychiatry

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 38

The power and pitfalls of underpowered studies

Carnahan, R. M., & Brown, G. D. (2024) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Statistical Methods in Clinical TrialsStatistical Methods in Epidemiology

Cited by 27

Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors

Bali, V., Chatterjee, S., Carnahan, R. M., Chen, H., Johnson, M. L., & Aparasu, R. R. (2015) · Psychiatric Services

Dementia and Cognitive Impairment ResearchTreatment of Major Depression

Cited by 23

Challenges and opportunities in creating a deprescribing program in the emergency department: A qualitative study

Lee, S., Bobb Swanson, M., Fillman, A., Carnahan, R. M., Seaman, A. T., & Reisinger, H. S. (2023) · Journal of the American Geriatrics Society

Pharmaceutical Practices and Patient OutcomesEmergency and Acute Care Studies

Cited by 16

Cardiovascular events in individuals treated with sulfonylureas or dipeptidyl peptidase 4 inhibitors

Turchin, A., Petito, L. C., Hegermiller, E., Carnahan, R., DeVries, A., Goel, S., Lansang, M. C., McDonnell, M. E., Nair, V., Priest, E., et al. (2025) · JAMA Network Open

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 14

Prevalence of anticholinergic medication use among elderly nursing home residents with depression

Chatterjee, S., Aparasu, R. R., Carnahan, R. M., Johnson, M. L., & Chen, H. (2014) · Value in Health

Pharmaceutical Practices and Patient OutcomesGeriatric Care and Nursing Homes

Cited by 6

Risk of dementia associated with the use of paroxetine among the elderly nursing home patients with depression

Bali, V., Aparasu, R. R., Johnson, M. L., Chen, H., & Carnahan, R. M. (2014) · Value in Health

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 4